Your browser doesn't support javascript.
loading
Factors leading to alpelisib discontinuation in patients with hormone receptor positive, human epidermal growth factor receptor-2 negative breast cancer.
Cheung, Yee-Ming M; Cromwell, Grace E; Tolaney, Sara M; Min, Le; McDonnell, Marie E.
Affiliation
  • Cheung YM; Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, 221 Longwood Ave, Boston, MA, 02115, USA.
  • Cromwell GE; Department of Medicine, Endocrine Unit, Austin Hospital, The University of Melbourne, Victoria, Australia.
  • Tolaney SM; Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, 221 Longwood Ave, Boston, MA, 02115, USA.
  • Min L; Department of Medical Oncology, Dana-Farber Cancer Institute, and Harvard Medical School, Boston, MA, 02215, USA.
  • McDonnell ME; Division of Endocrinology, Diabetes, and Hypertension, Department of Medicine, Brigham and Women's Hospital, and Harvard Medical School, 221 Longwood Ave, Boston, MA, 02115, USA.
Breast Cancer Res Treat ; 192(2): 303-311, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35000092
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Triple Negative Breast Neoplasms Type of study: Prognostic_studies Limits: Female / Humans / Middle aged Language: En Journal: Breast Cancer Res Treat Year: 2022 Document type: Article